4//SEC Filing
GOLDSTEIN JOSEPH L 4
Accession 0001708138-21-000076
CIK 0000872589other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:01 PM ET
Size
8.2 KB
Accession
0001708138-21-000076
Insider Transaction Report
Form 4
GOLDSTEIN JOSEPH L
Director
Transactions
- Sale
Common Stock
2021-09-10$650.00/sh−2,479$1,611,350→ 5,891 total - Exercise/Conversion
Common Stock
2021-09-10$380.95/sh+2,479$944,375→ 8,370 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-09-10−2,479→ 0 totalExercise: $380.95Exp: 2028-01-02→ Common Stock (2,479 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001225474
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:01 PM ET
- Size
- 8.2 KB